chuminhua2019-01-03 23:08
$Ohr制药(OHRP)$
12/3,NeuBase Therapeutics通过反向收购Ohr Pharmaceutical,在纳斯达克上市。NeuBase的模块化反义肽核酸(PNA)平台PATrOL用于改善基因沉默疗法。网页链接查看全文
$Ohr Pharmaceuticals, Inc.(OHRP)$ UPLOAD [Cover] - SEC-generated letter Filed: 2017-09-22 AccNo: 0000000000-17-033787 Size: 131 KB 网页链接
$Ohr Pharmaceuticals, Inc.(OHRP)$ 8-K - Current report Filed: 2017-10-20 AccNo: 0001387131-17-005118 Size: 26 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接
$Ohr Pharmaceuticals, Inc.(OHRP)$ 8-K - Current report Filed: 2017-10-10 AccNo: 0001387131-17-004990 Size: 20 KBItem 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 网页链接
$Ohr Pharmaceuticals, Inc.(OHRP)$ EFFECT - Notice of Effectiveness Filed: 2017-09-27 AccNo: 9999999995-17-002488 Size: 1 KB 网页链接
$Ohr Pharmaceuticals, Inc.(OHRP)$ 8-K - Current report Filed: 2017-09-15 AccNo: 0001387131-17-004694 Size: 29 KBItem 8.01: Other Events 网页链接
$Ohr Pharmaceuticals, Inc.(OHRP)$ S-3 - Registration statement under Securities Act of 1933 Filed: 2017-09-15 AccNo: 0001387131-17-004691 Size: 1 MB 网页链接
$Ohr Pharmaceuticals, Inc.(OHRP)$ 8-K - Current report Filed: 2017-09-15 AccNo: 0001387131-17-004694 Size: 29 KBItem 8.01: Other Events 网页链接
$Ohr Pharmaceuticals, Inc.(OHRP)$ S-3 - Registration statement under Securities Act of 1933 Filed: 2017-09-15 AccNo: 0001387131-17-004691 Size: 1 MB 网页链接
$Ohr Pharmaceuticals, Inc.(OHRP)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2017-08-08 AccNo: 0001387131-17-003985 Size: 1 MB 网页链接
$Ohr Pharmaceuticals, Inc.(OHRP)$ 8-K - Current report Filed: 2017-08-08 AccNo: 0001387131-17-003972 Size: 49 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接